Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (SLXN)

CUSIP: G1281K122

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Ordinary shares, par value $0.0135 per share
Shares outstanding
3,320,313
Total 13F shares
236,180
Share change
+96,011
Total reported value
$259,798
Price per share
$1.10
Number of holders
5
Value change
+$95,688
Number of buys
4
Number of sells
1

Sponsored

Quarterly Holders Quick Answers

What is CUSIP G1281K122?
CUSIP G1281K122 identifies SLXN - Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of SLXN - Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
CVI Investments, Inc.
13D/G
4.9%
456,531
$424,574 +$109,304 31 Mar 2025
Wildcat Capital Management, LLC
13F 3/4/5
Company · 10%+ Owner
3.4%
113,428
$227,990 31 Dec 2024
GOLDMAN SACHS GROUP INC
13D/G 13F
THE GOLDMAN SACHS GROUP, INC. · Company
2.4%
211,945
$197,109 +$92,724 31 Mar 2025
INTRACOASTAL CAPITAL, LLC
13D/G
Mitchell P. Kopin
5%
209,827
$195,139 $0 15 Jan 2025
UBS Group AG
13F
Company
0.45%
14,854
$29,857 31 Dec 2024
13F
Polar Asset Management Partners Inc.
13F
Company
class O/S missing
743,475
$25,501 31 Dec 2024
13F
HRT FINANCIAL LP
13F
Company
0.36%
11,887
$23,000 31 Dec 2024
13F
LINDEN ADVISORS LP
13F
Company
class O/S missing
337,500
$13,804 31 Dec 2024
13F
ARISTEIA CAPITAL, L.L.C.
13F
Company
class O/S missing
242,174
$9,905 31 Dec 2024
13F
Hartree Partners, LP
13F
Company
class O/S missing
187,500
$5,625 31 Dec 2024
13F
SECURITY BENEFIT LIFE INSURANCE CO /KS/
13F
Company
class O/S missing
150,000
$5,040 31 Dec 2024
13F
CLEAR STREET LLC
13F
Company
class O/S missing
145,441
$4,930 31 Dec 2024
13F
Kepos Capital LP
13F
Company
class O/S missing
100,000
$3,000 31 Dec 2024
13F
PERISCOPE CAPITAL INC.
13F
Company
class O/S missing
87,169
$2,955 31 Dec 2024
13F
JANE STREET GROUP, LLC
13F
Company
class O/S missing
75,721
$2,567 31 Dec 2024
13F
Yakira Capital Management, Inc.
13F
Company
class O/S missing
75,000
$2,543 31 Dec 2024
13F
Context Capital Management, LLC
13F
Company
class O/S missing
51,183
$1,735 31 Dec 2024
13F
TENOR CAPITAL MANAGEMENT Co., L.P.
13F
Company
class O/S missing
50,000
$1,695 31 Dec 2024
13F
Walleye Trading LLC
13F
Company
class O/S missing
35,000
$1,187 31 Dec 2024
13F
DUPONT CAPITAL MANAGEMENT CORP
13F
Company
class O/S missing
32,500
$1,102 31 Dec 2024
13F
Neuberger Berman Group LLC
13F
Company
class O/S missing
31,552
$1,070 31 Dec 2024
13F
PICTON MAHONEY ASSET MANAGEMENT
13F
Company
class O/S missing
57,175
$1,000 31 Dec 2024
13F
Mint Tower Capital Management B.V.
13F
Company
class O/S missing
25,000
$1,000 31 Dec 2024
13F
GTS SECURITIES LLC
13F
Company
class O/S missing
23,498
$799 31 Dec 2024
13F
STIFEL FINANCIAL CORP
13F
Company
class O/S missing
16,000
$542 31 Dec 2024
13F
RIVERNORTH CAPITAL MANAGEMENT, LLC
13F
Company
class O/S missing
14,999
$508 31 Dec 2024
13F
Saba Capital Management, L.P.
13F
Company
class O/S missing
11,937
$488 31 Dec 2024
13F
CITADEL ADVISORS LLC
13F
Company
class O/S missing
13,580
$456 31 Dec 2024
13F
COBBLESTONE CAPITAL ADVISORS LLC /NY/
13F
Company
class O/S missing
10,000
$339 31 Dec 2024
13F
WOLVERINE ASSET MANAGEMENT LLC
13F
Company
class O/S missing
8,735
$296 31 Dec 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
class O/S missing
265
$9 31 Dec 2024
13F
Ilan Shiloah
3/4/5
Director
class O/S missing
387,883
15 Aug 2024

Institutional Holders of Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (SLXN) as of Q1 2025

As of 31 Mar 2025, Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (SLXN) was held by 5 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 236,180 shares. The largest 5 holders included Wildcat Capital Management, LLC, UBS Group AG, MEYER HANDELMAN CO, SBI Securities Co., Ltd., and BANK OF AMERICA CORP /DE/. This page lists 5 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2025 vs Q4 2024 Across Filers

Q4 2024 holders
3
Q1 2025 holders
5
Holder diff
2
Investor Q4 2024 Shares Q1 2025 Shares Share Diff Share Chg % Q4 2024 Value $ Q1 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.